InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-6.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Dicicco Wendy F, Director. Director active across 4 companies, notably Renovacor, Inc.. Cumulatively, 10 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €18k. History available since 24 January 2022. The latest transaction was filed on 20 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Dicicco Wendy F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
2,567 shares@ US$7.79100.0% of flowCommon StockSEC:0001562180-24-006440:0
Canonical exit: 18 Nov 2024 (T+90)
158,473,915 shares0Ordinary Shares, par value $0.0001 per shareSEC:0000950170-24-053000:0
3,000 shares0Common StockSEC:0001562180-23-001336:0
1,120 shares@ US$17.6424.5% of flowCommon StockSEC:0001062993-23-000359:0
18,800 sharesCommon StockSEC:0001062993-22-023379:0
1,162 shares@ US$17.0026.6% of flowCommon StockSEC:0001062993-22-020197:0
1,137 shares@ US$17.4725.1% of flowCommon StockSEC:0000947871-22-000744:0
1,175 shares@ US$16.88100.0% of flowCommon StockSEC:0000947871-22-000437:0
2,500 shares0Common StockSEC:0001562180-22-001418:0
18,800 shares0Common StockSEC:0000899243-22-003303:0
10 of 10 declarations
About Dicicco Wendy F
Wendy F. DiCicco is the Interim Chief Financial Officer and a Board Member at Renovacor, Inc., EyePoint Pharmaceuticals, Inc., and SWK Holdings Corp. She oversees the financial operations of these companies, ensuring compliance and accuracy in financial reporting. Wendy plays a crucial role in managing financial resources while contributing to the strategic direction of each organization.
